Page 1 of 1

Lemtrada slows brain atrophy and reduces new MS lesions

Posted: Thu May 01, 2014 6:50 am
by MSUK
- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies. <br><br>

- Approximately 80 percent of patients treated with Lemtrada did not receive a third course of treatment in the first year of the extension........ Read more - http://www.ms-uk.org/lemtrada